IL165027A0 - Stabilized pharmaceutical compositions on the basis of polyoxythylated castor oil and method for manufacturing the same - Google Patents

Stabilized pharmaceutical compositions on the basis of polyoxythylated castor oil and method for manufacturing the same

Info

Publication number
IL165027A0
IL165027A0 IL16502703A IL16502703A IL165027A0 IL 165027 A0 IL165027 A0 IL 165027A0 IL 16502703 A IL16502703 A IL 16502703A IL 16502703 A IL16502703 A IL 16502703A IL 165027 A0 IL165027 A0 IL 165027A0
Authority
IL
Israel
Prior art keywords
polyoxythylated
basis
manufacturing
pharmaceutical compositions
same
Prior art date
Application number
IL16502703A
Other languages
English (en)
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Publication of IL165027A0 publication Critical patent/IL165027A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL16502703A 2002-06-10 2003-05-16 Stabilized pharmaceutical compositions on the basis of polyoxythylated castor oil and method for manufacturing the same IL165027A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20022027A CZ294371B6 (cs) 2002-06-10 2002-06-10 Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
PCT/EP2003/005153 WO2003103714A1 (en) 2002-06-10 2003-05-16 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same

Publications (1)

Publication Number Publication Date
IL165027A0 true IL165027A0 (en) 2005-12-18

Family

ID=29721409

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16502703A IL165027A0 (en) 2002-06-10 2003-05-16 Stabilized pharmaceutical compositions on the basis of polyoxythylated castor oil and method for manufacturing the same
IL165027A IL165027A (en) 2002-06-10 2004-11-04 Stabilized pharmaceutical compositions based on purified polyoxyethylated castor oil and methods for manufacturing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL165027A IL165027A (en) 2002-06-10 2004-11-04 Stabilized pharmaceutical compositions based on purified polyoxyethylated castor oil and methods for manufacturing the same

Country Status (19)

Country Link
US (1) US20050142225A1 (cs)
EP (1) EP1515751A1 (cs)
JP (1) JP2005534656A (cs)
KR (1) KR20050010030A (cs)
CN (1) CN1655824A (cs)
AU (1) AU2003240661A1 (cs)
BR (1) BR0311687A (cs)
CA (1) CA2487889A1 (cs)
CZ (1) CZ294371B6 (cs)
EA (1) EA007223B1 (cs)
HR (1) HRP20041107A2 (cs)
IL (2) IL165027A0 (cs)
IS (1) IS7551A (cs)
MX (1) MXPA04011990A (cs)
NZ (1) NZ537150A (cs)
PL (1) PL372071A1 (cs)
RS (1) RS106704A (cs)
WO (1) WO2003103714A1 (cs)
ZA (1) ZA200408892B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006097793A2 (en) 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
EP1690551A3 (en) 2005-02-10 2006-10-18 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
CA2597223A1 (en) * 2005-02-10 2006-08-17 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102008011691A1 (de) * 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
CN101596159B (zh) * 2008-06-03 2012-12-19 哈药集团生物工程有限公司 一种紫杉醇注射液及其制备方法
HUE033611T2 (en) 2008-09-17 2017-12-28 Chiasma Inc Pharmaceutical preparations and associated dosing procedures
CA2738732A1 (en) * 2008-11-21 2010-05-27 Boehringer Ingelheim International Gmbh Pharmaceutical composition of a potent hcv inhibitor for oral administration
PL2451438T3 (pl) 2009-07-07 2014-07-31 Boehringer Ingelheim Int Kompozycja farmaceutyczna inhibitora proteazy wirusowego zapalenia wątroby typu C
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
HK1247818A1 (zh) 2015-02-03 2018-10-05 Amryt Endo, Inc. 治疗疾病的方法
CN105497905A (zh) * 2015-12-30 2016-04-20 钟术光 一种供注射或口服用的辅料
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN112778513A (zh) * 2020-12-30 2021-05-11 江苏优仿医药科技有限公司 一种聚氧乙烯蓖麻油的精制方法及其应用
CN113281425B (zh) * 2021-04-15 2023-06-06 四川汇宇制药股份有限公司 一种聚氧乙烯(35)蓖麻油中游离脂肪酸的检测方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108823A (en) * 1979-02-13 1980-08-21 Takemoto Oil & Fat Co Ltd Purification of alkylene oxide addition compound
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
JPH02157274A (ja) * 1988-12-07 1990-06-18 Sumitomo Heavy Ind Ltd 植物油からビタミンeを分離濃縮する方法
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
CA2145190A1 (en) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Use of taxol for treating lymphomas and breast cancer
EP1500393A1 (en) * 1992-11-27 2005-01-26 Mayne Pharma (USA) Inc. Injectable composition containing taxol
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
CA2092271C (en) * 1993-03-09 2009-10-13 Eddie Reed Use of g-csf for treating taxol side-effects
PT2226085E (pt) * 1993-07-19 2014-03-04 Angiotech Pharm Inc Composições anti-angiogénicas e métodos de utilização
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE69613273T2 (de) * 1995-04-28 2001-10-31 Loders Croklaan B.V., Wormerveer An polyungesättigten Fettsäuren reiche Triglyceride
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
US5925776A (en) * 1997-12-24 1999-07-20 Schein Pharmacetical, Inc. Polyethoxylated castor oil, process of making the same and formulations thereof
JP2000044840A (ja) * 1998-07-28 2000-02-15 Mitsubishi Heavy Ind Ltd 燃料ガス漏洩検知塗膜
WO2000023070A1 (en) * 1998-10-20 2000-04-27 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceutical compositions
EP1262455A4 (en) * 1999-09-22 2006-01-25 Nippon Aerosil Co Ltd SURFACE MODIFIED, FINE SILICONE ACID POWDER AND ITS USE
JP2001247847A (ja) * 2000-03-03 2001-09-14 Nisshin Oil Mills Ltd:The 水性ゲル化剤
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

Also Published As

Publication number Publication date
EA007223B1 (ru) 2006-08-25
WO2003103714A1 (en) 2003-12-18
JP2005534656A (ja) 2005-11-17
IL165027A (en) 2009-12-24
US20050142225A1 (en) 2005-06-30
NZ537150A (en) 2006-09-29
CZ20022027A3 (cs) 2004-01-14
ZA200408892B (en) 2006-01-25
HRP20041107A2 (en) 2005-02-28
CA2487889A1 (en) 2003-12-18
RS106704A (en) 2006-12-15
AU2003240661A1 (en) 2003-12-22
CZ294371B6 (cs) 2004-12-15
IS7551A (is) 2004-11-25
EP1515751A1 (en) 2005-03-23
BR0311687A (pt) 2008-01-15
PL372071A1 (en) 2005-07-11
CN1655824A (zh) 2005-08-17
KR20050010030A (ko) 2005-01-26
EA200401625A1 (ru) 2005-06-30
MXPA04011990A (es) 2005-08-16

Similar Documents

Publication Publication Date Title
GB2374640B (en) Sliding bearing and method of manufacturing the same
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
IL165027A0 (en) Stabilized pharmaceutical compositions on the basis of polyoxythylated castor oil and method for manufacturing the same
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL158523A0 (en) Epothilone derivatives and pharmaceutical compositions containing the same
AU2002358270A1 (en) Zero-order sustained released dosage forms and method of making the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL197889A (en) Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
SG120978A1 (en) Metal-over-metal devices and the method for manufacturing same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
AU2003271060A1 (en) Bearing unit for wheel and method of manufacturing the bearing unit
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
AU2003285773A1 (en) Columnar structured material and method of manufacturing the same
TWI366202B (en) Multilayer chip varistor and method of manufacturing the same
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003254803A1 (en) Sliding part and method of manufacturing the sliding part
AU2003291443A1 (en) Compositions and processes for nanoimprinting
HRP20031067A2 (en) Pharmaceutical formulation having masked taste and method for the production thereof
AU2003276398A1 (en) Shearwall structure and method of making the same
AU2003284806A1 (en) Medicinal aerosol comprising plant essential oil and its preparation